AC Immune signs collaboration agreement with Nestlé Institute of Health Sciences to develop Alzheimer's disease diagnostic
23.September 2015 08:00 CET
- Development of minimally invasive Tau diagnostic assay for Alzheimer's disease
- Potential to identify Alzheimer's patients at very early and potentially pre-symptomatic stage of the disease
- Neurodegenerative expertise endorsed by fourth Tau collaboration